Amanote Research

Amanote Research

    RegisterSign In

Paradox of B Cell–targeted Therapies

Journal of Clinical Investigation - United States
doi 10.1172/jci37099
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

September 18, 2008

Authors
Tomohiro Kurosaki
Publisher

American Society for Clinical Investigation


Related search

Metastasis Targeted Therapies in Renal Cell Cancer

Üroonkoloji Bülteni
2018English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

Progress in Tumor Research
Cancer ResearchOncology
2014English

Targeted Biological Therapies for Graves’ Disease and Thyroid-Associated Ophthalmopathy. Focus on B-Cell Depletion With Rituximab

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2010English

T Cell Targeted Therapies in Lupus: Do They Make Sense?

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2015English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Review by Hui-Yuen Et Al. Targeted B-Cell Therapies in the Treatment of Adult and Paediatric Systemic Lupus Erythematosus

Lupus
Rheumatology
2016English

254. Next Generation SMART DRUGS: Aptamer-Based Cell-Targeted Cancer Therapies

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy